Amanote Research

Amanote Research

    RegisterSign In

Mighty RapaLink-1 Vanquishes Undruggable Mutant mTOR in Glioblastoma

Translational Cancer Research - China
doi 10.21037/tcr.2017.09.36
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncologyRadiologyNuclear MedicineImaging
Date

October 1, 2017

Authors
Meena Jhanwar-Uniyal
Publisher

AME Publishing Company


Related search

The Physiological mTOR Complex 1 Inhibitor DDIT4 Mediates Therapy Resistance in Glioblastoma

British Journal of Cancer
Cancer ResearchOncology
2019English

MIGHTY NORTH 1 Precision Test

1997English

EGFR and mTOR as Therapeutic Targets in Glioblastoma

Oncotarget
Oncology
2019English

MIghty Mouse

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2002English

Mighty Pup

Iowa Journal of Literary Studies
1991English

Mighty Bombing Run

Bulletin of the Atomic Scientists
International RelationsPolitical Science
1988English

Small but Mighty

Science
MultidisciplinaryPhilosophy of ScienceHistory
2018English

A Mighty Wind

Clinical Toxicology
MedicineToxicology
2008English

Q&A: Ashok Venkitaraman on “Undruggable” Targets

Cancer Discovery
Oncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy